PolyNovo Limited (PNV.AX)
AUD 1.06
(8.21%)
AUD 1.06
(8.21%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 5.26 Million AUD | 206.83% |
| 2023 | -4.92 Million AUD | -312.95% |
| 2022 | -1.19 Million AUD | 74.1% |
| 2021 | -4.6 Million AUD | -9.81% |
| 2020 | -4.19 Million AUD | -31.47% |
| 2019 | -3.18 Million AUD | 46.6% |
| 2018 | -5.97 Million AUD | -19.34% |
| 2017 | -5 Million AUD | -63.5% |
| 2016 | -3.06 Million AUD | -135.09% |
| 2015 | -1.3 Million AUD | 55.64% |
| 2014 | -2.93 Million AUD | -96.75% |
| 2013 | -1.49 Million AUD | 44.71% |
| 2012 | -2.69 Million AUD | 7.46% |
| 2011 | -2.91 Million AUD | -56.7% |
| 2010 | -1.86 Million AUD | -1.71% |
| 2009 | -1.83 Million AUD | 58.79% |
| 2008 | -4.44 Million AUD | 66.87% |
| 2007 | -13.4 Million AUD | -18.71% |
| 2006 | -11.29 Million AUD | -4.92% |
| 2005 | -10.76 Million AUD | 0.0% |
| 2004 | - AUD | 100.0% |
| 2003 | -8.57 Million AUD | -49.54% |
| 2002 | -5.73 Million AUD | -13.02% |
| 2001 | -5.07 Million AUD | -42.31% |
| 2000 | -3.56 Million AUD | -117.86% |
| 1999 | -1.63 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 2.56 Million AUD | 0.0% |
| 2024 Q2 | 2.69 Million AUD | 0.0% |
| 2024 FY | 5.26 Million AUD | 206.83% |
| 2023 Q4 | -1.1 Million AUD | 0.0% |
| 2023 FY | -4.92 Million AUD | -312.95% |
| 2023 Q2 | -3.82 Million AUD | 0.0% |
| 2022 Q4 | -2.81 Million AUD | 0.0% |
| 2022 Q2 | 1.61 Million AUD | 0.0% |
| 2022 FY | -1.19 Million AUD | 74.1% |
| 2021 FY | -4.6 Million AUD | -9.81% |
| 2021 Q2 | -3.53 Million AUD | 0.0% |
| 2021 Q4 | -1.06 Million AUD | 0.0% |
| 2020 FY | -4.19 Million AUD | -31.47% |
| 2020 Q2 | -2.41 Million AUD | 0.0% |
| 2020 Q4 | -1.77 Million AUD | 0.0% |
| 2019 Q2 | -1.91 Million AUD | 0.0% |
| 2019 Q4 | -1.27 Million AUD | 0.0% |
| 2019 FY | -3.18 Million AUD | 46.6% |
| 2018 FY | -5.97 Million AUD | -19.34% |
| 2018 Q2 | -3.22 Million AUD | 0.0% |
| 2018 Q4 | -2.74 Million AUD | 0.0% |
| 2017 Q2 | -1.96 Million AUD | 0.0% |
| 2017 FY | -5 Million AUD | -63.5% |
| 2017 Q4 | -3.04 Million AUD | 0.0% |
| 2016 Q4 | -920.76 Thousand AUD | 0.0% |
| 2016 Q2 | -2.14 Million AUD | 0.0% |
| 2016 FY | -3.06 Million AUD | -135.09% |
| 2015 FY | -1.3 Million AUD | 55.64% |
| 2015 Q4 | 137.89 Thousand AUD | 0.0% |
| 2015 Q2 | -1.44 Million AUD | 0.0% |
| 2014 FY | -2.93 Million AUD | -96.75% |
| 2014 Q4 | -1.78 Million AUD | 0.0% |
| 2014 Q2 | -1.14 Million AUD | 0.0% |
| 2013 Q3 | -373.1 Thousand AUD | 36.15% |
| 2013 Q4 | -908.1 Thousand AUD | -143.39% |
| 2013 FY | -1.49 Million AUD | 44.71% |
| 2013 Q2 | -584.32 Thousand AUD | 13.42% |
| 2013 Q1 | -674.86 Thousand AUD | 0.0% |
| 2012 Q2 | -674.86 Thousand AUD | 7.46% |
| 2012 Q1 | -729.28 Thousand AUD | 0.0% |
| 2012 Q4 | -674.86 Thousand AUD | 0.0% |
| 2012 Q3 | -674.86 Thousand AUD | 0.0% |
| 2012 FY | -2.69 Million AUD | 7.46% |
| 2011 Q4 | -729.28 Thousand AUD | 0.0% |
| 2011 Q1 | -465.38 Thousand AUD | 0.0% |
| 2011 FY | -2.91 Million AUD | -56.7% |
| 2011 Q3 | -729.28 Thousand AUD | 0.0% |
| 2011 Q2 | -729.28 Thousand AUD | -56.7% |
| 2010 Q2 | -465.38 Thousand AUD | -1.71% |
| 2010 FY | -1.86 Million AUD | -1.71% |
| 2010 Q3 | -465.38 Thousand AUD | 0.0% |
| 2010 Q4 | -465.38 Thousand AUD | 0.0% |
| 2010 Q1 | -457.54 Thousand AUD | 0.0% |
| 2009 FY | -1.83 Million AUD | 58.79% |
| 2009 Q3 | -457.54 Thousand AUD | 0.0% |
| 2009 Q1 | -1.11 Million AUD | 0.0% |
| 2009 Q4 | -457.54 Thousand AUD | 0.0% |
| 2009 Q2 | -457.54 Thousand AUD | 58.79% |
| 2008 Q1 | -3.35 Million AUD | 0.0% |
| 2008 FY | -4.44 Million AUD | 66.87% |
| 2008 Q4 | -1.11 Million AUD | 0.0% |
| 2008 Q3 | -1.11 Million AUD | 0.0% |
| 2008 Q2 | -1.11 Million AUD | 66.87% |
| 2007 Q2 | -3.35 Million AUD | -18.71% |
| 2007 Q4 | -3.35 Million AUD | 0.0% |
| 2007 Q3 | -3.35 Million AUD | 0.0% |
| 2007 FY | -13.4 Million AUD | -18.71% |
| 2007 Q1 | -2.82 Million AUD | 0.0% |
| 2006 Q3 | -2.82 Million AUD | 0.0% |
| 2006 Q4 | -2.82 Million AUD | 0.0% |
| 2006 FY | -11.29 Million AUD | -4.92% |
| 2006 Q2 | -2.82 Million AUD | -4.92% |
| 2006 Q1 | -2.69 Million AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q4 | -2.69 Million AUD | 0.0% |
| 2005 Q3 | -2.69 Million AUD | 0.0% |
| 2005 Q2 | -2.69 Million AUD | 0.0% |
| 2005 FY | -10.76 Million AUD | 0.0% |
| 2004 Q1 | -2.14 Million AUD | 0.0% |
| 2004 FY | - AUD | 100.0% |
| 2004 Q2 | - AUD | 100.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2003 Q3 | -2.14 Million AUD | 0.0% |
| 2003 Q4 | -2.14 Million AUD | 0.0% |
| 2003 Q2 | -2.14 Million AUD | -49.53% |
| 2003 Q1 | -1.43 Million AUD | 0.0% |
| 2003 FY | -8.57 Million AUD | -49.54% |
| 2002 Q3 | -1.43 Million AUD | 0.0% |
| 2002 Q4 | -1.43 Million AUD | 0.0% |
| 2002 Q2 | -1.43 Million AUD | -13.02% |
| 2002 FY | -5.73 Million AUD | -13.02% |
| 2002 Q1 | -1.26 Million AUD | 0.0% |
| 2001 Q3 | -1.26 Million AUD | 0.0% |
| 2001 FY | -5.07 Million AUD | -42.31% |
| 2001 Q4 | -1.26 Million AUD | 0.0% |
| 2001 Q2 | -1.26 Million AUD | -42.31% |
| 2001 Q1 | -890.85 Thousand AUD | 0.0% |
| 2000 FY | -3.56 Million AUD | -117.86% |
| 2000 Q1 | -408.91 Thousand AUD | 0.0% |
| 2000 Q2 | -890.85 Thousand AUD | -117.86% |
| 2000 Q3 | -890.85 Thousand AUD | 0.0% |
| 2000 Q4 | -890.85 Thousand AUD | 0.0% |
| 1999 Q2 | -408.91 Thousand AUD | 0.0% |
| 1999 Q3 | -408.91 Thousand AUD | 0.0% |
| 1999 Q4 | -408.91 Thousand AUD | 0.0% |
| 1999 FY | -1.63 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 114.623% |
| Adherium Limited | -10.22 Million AUD | 151.456% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 153.969% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 176.828% |
| Anteris Technologies Ltd | -67.33 Million AUD | 107.813% |
| Control Bionics Limited | -5.91 Million AUD | 188.962% |
| CardieX Limited | -6.76 Million AUD | 177.764% |
| Compumedics Limited | -338 Thousand AUD | 1656.509% |
| Cochlear Limited | 356.8 Million AUD | 98.526% |
| CleanSpace Holdings Limited | -3.12 Million AUD | 268.237% |
| Cyclopharm Limited | -4.7 Million AUD | 211.917% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | 292.738% |
| Nova Eye Medical Limited | -8.79 Million AUD | 159.852% |
| HeraMED Limited | -6.78 Million AUD | 177.554% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 123.252% |
| ImpediMed Limited | -19.79 Million AUD | 126.584% |
| InhaleRx Limited | -1.44 Million AUD | 464.519% |
| LBT Innovations Limited | -3.74 Million AUD | 240.668% |
| Micro-X Limited | -9.76 Million AUD | 153.876% |
| Neurotech International Limited | -5.06 Million AUD | 203.783% |
| OncoSil Medical Limited | -11.91 Million AUD | 144.159% |
| Respiri Limited | -7.12 Million AUD | 173.795% |
| SomnoMed Limited | -12.24 Million AUD | 142.976% |
| Universal Biosensors, Inc. | -6.74 Million AUD | 178.038% |
| Uscom Limited | -2.07 Million AUD | 353.573% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | 203.904% |